End-to-End Supply Chain Audit & Benchmarking for a Leading Pharma Division
Client Overview
A top-tier Indian pharmaceutical company engaged our consulting services to conduct a comprehensive audit of its high-performing domestic division, which generates annual revenues of ₹600–700 Cr. The engagement focused on optimizing supply chain efficiency, improving competitive positioning, and identifying cost-saving opportunities.
Challenge
Although the division had strong revenue performance, inefficiencies in supply chain operations and limited market intelligence were creating hidden costs and strategic blind spots. The client wanted to gain insights on:
a) Benchmark pricing and procurement practices, especially around APIs.
b) Monitor and improve CNF (Clearing & Forwarding) and stockist performance.
c) Gain visibility into competitive activities and emerging market trends.
d) Identify gaps in the product portfolio and execution strategy.
Approach
Our team led a detailed, comprehensive analysis encompassing both internal supply chain audits and external market assessments.
1. Supply Chain Audit & Operational Efficiency
Audited all CNF and stockist partners across India to assess operational effectiveness and cost efficiency. Identified process gaps, inventory imbalances, and logistics inefficiencies. Proposed a set of targeted interventions to streamline distribution and reduce working capital pressure.
2. API Price Benchmarking
Conducted price benchmarking across key APIs used in the division’s portfolio.
Evaluated supplier competitiveness and aligned procurement strategies with market norms to unlock
cost advantages.
3. Competitive Intelligence & Brand Monitoring
Built a structured CI (Competitive Intelligence) system to continuously track competitor brands—what they are launching, how they are positioning themselves, and where they are gaining traction. Enabled the commercial team to make quicker, data-driven decisions on brand strategy and market response.
4. Portfolio Gap Analysis
Analysed market trends and competitor pipelines to identify gaps in the current portfolio. Recommended potential new therapy areas, formulation improvements, or brand repositioning strategies to better align with market needs.
Outcome and Impact
Identified ₹5 Cr in annual recurring savings through supply chain optimization and better procurement. Improved alignment between logistics infrastructure and market demand. Established a robust competitive intelligence mechanism for ongoing brand monitoring. Enabled leadership to make informed decisions on product strategy and growth focus areas.